These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 36352098)

  • 61. Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment.
    Affandi AJ; Radstake TR; Marut W
    Semin Immunopathol; 2015 Sep; 37(5):475-87. PubMed ID: 26168983
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
    Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
    Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients.
    Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A
    Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis.
    Artlett CM; Sassi-Gaha S; Rieger JL; Boesteanu AC; Feghali-Bostwick CA; Katsikis PD
    Arthritis Rheum; 2011 Nov; 63(11):3563-74. PubMed ID: 21792841
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Unfolding the pathogenesis of scleroderma through genomics and epigenomics.
    Tsou PS; Sawalha AH
    J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis.
    Moezinia C; Wong V; Watson J; Nagib L; Lopez Garces S; Zhang S; Ahmed Abdi B; Newton F; Abraham D; Stratton R
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887334
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Emerging roles of innate immune signaling and toll-like receptors in fibrosis and systemic sclerosis.
    Bhattacharyya S; Varga J
    Curr Rheumatol Rep; 2015 Jan; 17(1):474. PubMed ID: 25604573
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review.
    McGaugh S; Kallis P; De Benedetto A; Thomas RM
    Dermatol Ther; 2022 Jun; 35(6):e15437. PubMed ID: 35278019
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Type I interferon dysregulation in Systemic Sclerosis.
    Skaug B; Assassi S
    Cytokine; 2020 Aug; 132():154635. PubMed ID: 30685202
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
    Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
    Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging.
    De Luca G; Bombace S; Monti L
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):343-357. PubMed ID: 35072931
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypothesis: pathogenesis of systemic sclerosis.
    Takehara K
    J Rheumatol; 2003 Apr; 30(4):755-9. PubMed ID: 12672195
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis.
    Worrell JC; O'Reilly S
    J Autoimmun; 2020 Sep; 113():102526. PubMed ID: 32713676
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
    Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
    J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathophysiology of systemic sclerosis.
    Thoreau B; Chaigne B; Renaud A; Mouthon L
    Presse Med; 2021 Apr; 50(1):104087. PubMed ID: 34718115
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytokine-producing B-cell balance associates with skin fibrosis in patients with systemic sclerosis.
    Horii M; Fushida N; Ikeda T; Oishi K; Hamaguchi Y; Ikawa Y; Komuro A; Matsushita T
    J Dermatol; 2022 Oct; 49(10):1012-1019. PubMed ID: 35751840
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?
    Luckhardt TR; Thannickal VJ
    Curr Opin Rheumatol; 2015 Nov; 27(6):571-6. PubMed ID: 26398012
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis.
    Xu D; Mu R; Wei X
    Front Immunol; 2019; 10():2025. PubMed ID: 31572353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase-like 4: New Evidence From Three-Dimensional Skin-like Tissues.
    Huang M; Cai G; Baugh LM; Liu Z; Smith A; Watson M; Popovich D; Zhang T; Stawski LS; Trojanowska M; Georgakoudi I; Black LD; Pioli PA; Whitfield ML; Garlick J
    Arthritis Rheumatol; 2020 May; 72(5):791-801. PubMed ID: 31705627
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.
    Gourh P; Agarwal SK; Divecha D; Assassi S; Paz G; Arora-Singh RK; Reveille JD; Shete S; Mayes MD; Arnett FC; Tan FK
    Arthritis Rheum; 2009 Dec; 60(12):3794-806. PubMed ID: 19950257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.